CustoMED completed its seed round, bringing total funding to $6 million, including investment from an unnamed leading orthopedic implant company.
Proceeds will accelerate CustoMED’s expansion into additional automated orthopedic indications, support U.S. and EU regulatory milestones—with approvals anticipated for 2026—and enable the global deployment of its on-demand manufacturing model.
CustoMED’s cloud-based platform combines artificial intelligence and automation with 3D printing to generate surgical tools and implants directly from a surgeon’s pre-operative plan within minutes, instead of weeks. The patient-specific devices are produced onsite or through certified partners and integrate into existing surgical workflows. The technology has already been used in hundreds of successful surgeries worldwide, with thousands more planned for the coming year.
“CustoMED’s patient-specific surgical tools enable more precise orthopedic surgeries through affordable, real-time solutions delivered directly into the operating room,” said Or Benifla, Co-founder of CustoMED. “By putting scalable, personalized technology directly in surgeons’ hands, our mission is to make computer-guided surgery fast, accessible, and routine, transforming what was once a boutique process into standard of care for every patient.”
CustoMED completed its seed round, bringing total funding to $6 million, including investment from an unnamed leading orthopedic implant company.
Proceeds will accelerate CustoMED's expansion into additional automated orthopedic indications, support U.S. and EU regulatory milestones—with approvals anticipated for 2026—and enable the global...
CustoMED completed its seed round, bringing total funding to $6 million, including investment from an unnamed leading orthopedic implant company.
Proceeds will accelerate CustoMED’s expansion into additional automated orthopedic indications, support U.S. and EU regulatory milestones—with approvals anticipated for 2026—and enable the global deployment of its on-demand manufacturing model.
CustoMED’s cloud-based platform combines artificial intelligence and automation with 3D printing to generate surgical tools and implants directly from a surgeon’s pre-operative plan within minutes, instead of weeks. The patient-specific devices are produced onsite or through certified partners and integrate into existing surgical workflows. The technology has already been used in hundreds of successful surgeries worldwide, with thousands more planned for the coming year.
“CustoMED’s patient-specific surgical tools enable more precise orthopedic surgeries through affordable, real-time solutions delivered directly into the operating room,” said Or Benifla, Co-founder of CustoMED. “By putting scalable, personalized technology directly in surgeons’ hands, our mission is to make computer-guided surgery fast, accessible, and routine, transforming what was once a boutique process into standard of care for every patient.”
Copy to clipboard 
